affect the interaction of ∆F508-CFTR with specific molecular chaperones (25) (26) (27) (28) . Genistein, an isoflavone with tyrosine kinase and topoisomerase inhibitor activities, enhances functional ∆F508-CFTR Cl -channel expression in epithelial and non-epithelial cells via increases in channel open probability (29) . Previous studies have concentrated on assessing changes in mutant CFTR-mediated Cl -transport in response to chemical or pharmacological agents, such as 4-phenylbutyrate, glycerol, and genistein. However, assessment of mutant CFTR-mediated regulation of Na + transport in response to these pharmacological agents has received limited attention. We utilized the Xenopus oocyte expression system to examine whether genistein restores ∆F508-CFTR regulatory interactions with ENaC, as previous studies have shown that ∆F508-CFTR is expressed at the oocyte cell surface (30) . We observed that ∆F508-CFTR does not inhibit the functional expression of ENaC, in agreement with previous data (31) . Furthermore, ENaC did not enhance the functional expression of ∆F508-CFTR. However, we observed that genistein restores functional interactions between ∆F508-CFTR and ENaC, suggesting that combinations of pharmacologic agents may prove beneficial for the repair of mutant CFTR function.
Experimental Procedures

Materials
Forskolin, IBMX and genistein were purchased from Sigma Chemical Co. (St. Louis, MO). All other reagents were purchased from Fisher Chemical Co.
Expression of human CFTR (wild type (WT) and ∆F508) and mouse ENaC in Xenopus oocytes
Human CFTR (WT and ∆F508) and mouse ENaC were expressed in Xenopus oocytes essentially as previously described (7) . Briefly, human WT-CFTR, human ∆F508-CFTR, and mouse α-, β-, and γENaC cRNAs were prepared using a cRNA synthesis kit (mMESSAGE mMACHINE, Ambion Inc, Austin, TX) according to the manufacturer's protocol. cRNA concentrations were determined spectroscopically. Oocytes obtained from adult female Xenopus laevis (NASCO, Fort Atkinson, WI) were enzymatically defolliculated and maintained at 18º C in modified Barth's saline (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 0.3 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 15 mM Hepes, pH 7.6 supplemented with 10 µg/ml sodium penicillin, 10 µg/ml streptomycin sulfate and 100 µg/ml gentamicin sulfate). Each batch of oocytes obtained from an individual frog were injected with either α-, β-, and γ-subunits of ENaC (0.33 ng/subunit), WT-CFTR (10 ng), ∆F508-CFTR (10 ng), or a combination of ENaC and CFTR (WT or ∆F508) cRNAs dissolved in RNase-free water using a Nanoject II microinjector (Drummond Scientific, Broomall, PA).
Electrophysiological analyses
Whole-cell current measurements were performed 24 to 48 hours after injection using the two-electrode voltage clamp method as previously described (7) . Oocytes were placed in a 1 ml chamber containing modified ND96 (96 mM NaCl, 1 mM KCl, 0.2 mM CaCl 2 , 5.8 mM MgCl 2 , 10 mM Hepes, pH 7.4), and impaled with micropipettes of 0.5-5 MΩ resistance filled with 3M KCl. The whole-cell currents were measured by voltage clamping the oocytes in 20 mV steps between -140 mV to +60 mV adjusted for baseline transmembrane potential. Whole cell currents (I) were digitized at 200 Hz during the voltage steps, recorded directly onto a hard disk and analyzed using pClamp 8 software (Axon Instruments, Foster City, CA). Ion replacement studies were performed in an identical manner except that equimolar N-methyl-Dglucamine (NMDG) replaced Na + in the ND96 solution. To reduce error due to series resistance, the voltage clamp (Axon Geneclamp 500B) was configured to clamp the bath potential to 0 mV. In this configuration, we independently monitored the oocyte membrane potential during our clamp protocol. We routinely observed membrane potentials that were <5% depolarized from our target holding potentials, despite high conductances observed in oocytes expressing ENaC and WT-CFTR.
The difference in whole-cell currents measured in the absence and presence of 10 µM amiloride was used to define the amiloridesensitive Na + current that was carried by ENaC.
Activation of WT-or ∆F508-CFTR was accomplished by perfusion of the oocyte with buffer supplemented with 10 µM forskolin and 100 µM IBMX for 25 minutes (7). In some experiments this first step was followed by an incubation with 10 µM forskolin, 100 µM IBMX and 50 µM genistein for 20 minutes. In all experiments, ∆F508-CFTR Cl -current was defined as the difference between current measured 20 min after perfusion with forskolin/IBMX (or 15 min 6 by guest on November 19, 2017 http://www.jbc.org/ Downloaded from after perfusion with forskolin/IBMX/genistein), and the current measured prior to forskolin/IBMX (+/-genistein) stimulation. Whole-cell currents were recorded at -100 mV for comparisons. All measurements were performed at room temperature.
Statistical Analyses
Statistical comparisons were performed using the Student's t test. A pair wise t test was used for pre/post treatment in experiments using an individual oocyte. A 2-tailed t test was used when comparing currents obtained from oocytes injected with a cRNA for a single transporter (i.e., ENaC or CFTR (WT or ∆F508)) versus oocytes co-injected with a cRNAs for both ENaC and CFTR (WT or ∆F508). p values < 0.05 were accepted to indicate statistical significance.
Results
Expression of ∆F508-CFTR and ENaC in Xenopus oocytes
The Xenopus oocyte expression system was used to examine the functional expression of ∆F508-CFTR and its functional interaction with ENaC. Although ∆F508-CFTR is a trafficking defective mutant, ∆F508-CFTR is delivered to the oocyte plasma membrane (30) 
Co-expression of WT-CFTR and αβγENaC in Xenopus oocytes
Several groups have previously reported that when WT-CFTR and ENaC were co-expressed in Xenopus oocytes, ENaC-mediated Na + currents were inhibited in response to CFTR activation (4-7). Furthermore, ENaC enhances forskolin/IBMX-stimulated CFTR Clcurrents (5-7). Figure 2 shows whole cell currents measured at a holding potential of -100mV in oocytes injected with cRNAs for WT-CFTR (10ng) or αβγENaC (0.33ng/subunit), or coinjected with cRNAs for both WT-CFTR and αβγENaC. Oocytes co-injected with both CFTR and ENaC expressed an amiloride-sensitive whole cell current (-1.3 + 0.3 µA at 100 mV) in the absence of forskolin/IBMX. Following CFTR activation with forskolin/IBMX, the amiloridesensitive whole cell current was reduced to -0.7 + 0.2 µA (Fig. 2 , n=15, p<0.01).
The forskolin/IBMX-stimulated amiloride-insensitive whole cell current measured at a clamp potential of -100 mV in oocytes co-expressing WT-CFTR and ENaC (-7.6 + 2.1 µA; n=15) was 3.5-fold greater than that obtained in oocytes expressing CFTR alone (-2.2 + 0.4 µA; n=18; p=0.01; Fig 2) . The larger forskolin/IBMX-stimulated amiloride-insensitive current in oocytes expressing both CFTR and ENaC, compared with oocytes expressing CFTR alone, is in agreement with previous reports that ENaC enhances functional CFTR expression (5-7).
Co-expression of ∆F508-CFTR and αβγENaC
Whole cell currents measured at a clamp potential of 100 mV in oocytes injected with cRNAs for either ∆F508-CFTR (10 ng), αβγENaC (0.33 ng/subunit), or both ∆F508-CFTR and αβγENaC are shown in Fig. 3 . Oocytes co-injected with both ∆F508-CFTR and ENaC expressed amiloride-sensitive whole cell currents (-5.1 + 0.7 µA) in the absence of forskolin/IBMX.
Following ∆F508-CFTR activation with forskolin/IBMX, the amiloride-sensitive whole cell current was essentially unchanged (-4.9 + 0.6 µA, n=19, p=ns), in agreement with previous studies (31) . Furthermore, forskolin/IBMX-stimulated whole cell currents in oocytes expressing ∆F508-CFTR alone (-1.3 + 0.3 µA) and amiloride-insensitive forskolin/IBMX-stimulated whole cell currents in oocytes expressing ∆F508-CFTR and ENaC (-1.6 + 0.3 µA) were similar in magnitude (n=19; p=ns). These data are consistent with a lack of functional regulatory interactions between ∆F508-CFTR and ENaC expressed in Xenopus oocytes.
Genistein restores functional interactions between ∆F508-CFTR and αβγENaC
Previous studies reported that the open probability of ∆F508-CFTR is lower than the open probability of WT-CFTR (35) . Furthermore, the open probability of both ∆F508-CFTR and WT-CFTR have been reported to increase in response to the isoflavone genistein (29) . We therefore examined whether genistein restored functional interactions between ∆F508-CFTR and ENaC. Linear whole cell I/V relationships were observed in oocytes expressing ∆F508-CFTR ( Previous studies suggested that chronic treatment with genistein inhibits ENaC by reducing surface expression of Na + channels in A6 renal epithelial cells (36, 37) . In contrast, protein kinase A activates ENaC in part via an increase in surface expression of channels (38,39).
Amiloride-sensitive whole cell currents were measured in oocytes expressing ENaC prior to and after 15 min incubation with 10 µM forskolin/100 µM IBMX/50 µM genistein ( ± 0.5-fold (p<0.05) increase in forskolin/IBMX/genistein-stimulated amiloride-insensitive current in oocytes co-expressing ∆F508-CFTR/ENaC (n=12), when compared to oocytes expressing ∆F508-CFTR alone (n=13) was also observed when bath Na + was replaced with the impermeant cation NMDG + (Fig 6) .
These data suggest that ENaC enhances the forskolin/IBMX/genistein-mediated activation of ∆F508-CFTR. Furthermore, this enhanced activation ∆F508-CFTR is not dependent on ENaC-mediated Na + transport.
Whole cell amiloride-sensitive currents observed after stimulation by forskolin/IBMX/genistein in oocytes expressing ENaC and ∆F508-CFTR (-5.6 + 0.6 µA, n=24)
were significantly lower than the amiloride-sensitive currents obtained after stimulation by forskolin/IBMX/genistein in oocytes expressing ENaC alone (-9.0 + 0.9 µA, n=23, p=0.003).
Although amiloride-sensitive whole cell currents significantly increased in oocyte expressing ENaC alone following stimulation by forskolin/IBMX/genistein (Fig. 5) , the amiloride-sensitive currents recorded in oocytes co-expressing ENaC and ∆F508-CFTR remained stable following stimulation with forskolin/IBMX/genistein (-5.2 ± 0.7 (-forskolin/IBMX/genistein) versus -5.6 ± 0.6 µA (+forskolin/IBMX/genistein); n=24; p=ns). These data suggest that activation of ∆F508-CFTR by forskolin/IBMX in the presence of genistein partially restores CFTR-mediated inhibition of ENaC activity.
Functional interactions between WT-CFTR and ENaC were examined in oocytes treated
with genistein ( Fig. 7) . Whole cell currents measured in oocytes co-expressing WT-CFTR and ENaC in response to forskolin/IBMX/genistein were -13.0 ± 1.9 µA (n=12; Fig. 7 ), 5.2-fold greater than forskolin/IBMX/genistein-stimulated currents in oocytes expressing CFTR alone (-2.5 ± 0.5 µA, n=13 p<0.001). Furthermore, oocytes co-expressing WT-CFTR and ENaC responded to forskolin/IBMX/genistein with a modest, but statistically insignificant reduction in amiloride-sensitive whole cell currents ( Fig. 7 ; -3.2 ± 0.6 µA, (-forskolin/IBMX/genistein); -2.6 ± 0.5 µA, (+forskolin/IBMX/genistein); n=12; p=ns).
Discussion
CFTR is a Cl --selective channel as well as a regulator of other epithelial channels and transport proteins. In cystic fibrosis, the absence of CFTR in the airway epithelia leads to hyperactive ENaC, which is hypothesized to lead to enhanced reabsorption of airway fluids and impaired mucociliary clearance (40) . ENaC hyperactivity results in hyperpolarization of airway epithelia, as is evidenced by increases in the change in transepithelial potential of the nasal airway in response to amiloride (41) . In contrast, activation of CFTR in sweat ducts leads to an enhancement in ENaC activity, suggesting that regulatory interactions between CFTR and ENaC may be tissue specific (9) . (Fig. 5) . Furthermore, the enhanced activation ∆F508-CFTR by ENaC is not dependent on ENaC-mediated Na + transport (Fig. 6 ). These data argue that Cl -and Na + conductances are not the sole determinants of CFTR/ENaC interactions.
Previous studies have demonstrated that regulatory interactions between CFTR and
Nagel and co-workers suggested that the apparent CFTR-mediated inhibition of ENaC reflected a series resistor error (47). Our voltage clamp was configured to clamp the bath potential to 0 mV to diminish the likelihood of series resistor errors. Furthermore, in this configuration we independently monitored oocyte membrane potential during our clamp protocol and, even at high conductances, routinely observed membrane potentials that were <5 % depolarized from our target holding potentials. In addition, the cAMP-regulated conductance in oocytes co-expressing CFTR and ENaC was significantly greater than that observed in oocytes expressing CFTR alone ( Changes in whole cell currents that were not inhibited by 10 µM amiloride (presumed to be ∆F508-CFTR-mediated) were determined following stimulation with 10µM forskolin/100 µM IBMX/50 µM genistein in standard ND96 (NaCl) buffer. NMDG-Cl96: Changes in whole cell currents were determined following stimulation with 10µM forskolin/100 µM IBMX/50 µM genistein in oocytes bathed in a Na + -free solution (Na + was replaced with N-methyl-Dglucamine (NMDG)). Data (means + SEM) are expressed relative to the mean change in whole cell current of oocytes injected with ∆F508-CFTR alone. 
